Vector Science and Therapeutics Corp. develops and sells novel biomechanical devices and active localized drug-delivery platforms. The company offers products and services based on its Smart, Steered, and Sustained framework for site-direct…
Sign in to search companies, open filing PDFs, fetch uncached SEDAR+ documents, and use the
full company research view.
Transactions 2026-05-13 M&A
Vector Science & Therapeutics Agrees to an Option to Invest in LyoGenesis Plus, Securing Long-Term Access to FDA-Registered, cGMP Manufacturing
News release - English.pdf
Transactions 2026-05-11 M&A
Vector Science & Therapeutics Enters Three-Year Development and Manufacturing Agreement with MPP Group LLC
News release - English.pdf
Results 2026-05-04
Interim MD&A - English.pdf
Results 2026-05-04
Interim financial statements/report – English.pdf
Results 2026-05-04
Financial statements of RTO acquirer.pdf
News 2026-05-01
Vector Science & Therapeutics Files Provisional Patent for Novel Microneedle Catheter Platform for Intratumoral Drug Delivery
News release - English.pdf
Ownership 2026-04-24
Other securityholders documents - English.pdf
Transactions 2026-04-24 Financing
Material document(s).pdf
Transactions 2026-04-24 M&A
Vector Science and Therapeutics Corp. Announces Completion of Qualifying Transaction and Name Change
Material change report - English.pdf
Transactions 2026-04-14 M&A
OpenSesame Announces Entering Into Acquisition Agreement and Filing of Filing Statement for Qualifying Transaction
News release - English.pdf
Results 2026-04-11
Annual MD&A - English.pdf
Results 2026-04-11
Audited annual financial statements – English.pdf
Transactions 2026-03-17 Financing
OpenSesame Provides Update on the Terms of the Subscription Receipt Offering
News release - English.pdf
Results 2025-12-02 Financials
Interim financial statements/report – English.pdf
Results 2025-12-02 Financials
Interim MD&A - English.pdf
News 2025-11-25
Other.pdf
News 2025-11-25
Other.pdf
News 2025-10-06
News release - English.pdf
Results 2025-08-29 Financials
Interim MD&A - English.pdf
Results 2025-08-29 Financials
Interim financial statements/report – English.pdf